BioCentury | Mar 10, 2011
Distillery Therapeutics

Indication: Infectious disease

...aureus ribonuclease P (RnpA) In vitro and mouse studies identified a small molecule inhibitor of RnpA...
...could help treat S. aureus infection. High throughput screening identified lead compound RNPA1000, which inhibited RnpA-mediated...
BioCentury | Oct 23, 1995
Company News

Genetics Institute, Bristol-Myers deal

...Bristol-Myers (Princeton, N.J.) will develop GENIZ's recombinant novel plasminogen activator (rNPA). Bristol-Myers will conduct Phase II...
...million over the next two years in exchange for worldwide manufacturing and marketing rights to rNPA...
Items per page:
1 - 2 of 2